BCA
EOLS icon

Buckley Capital Advisors’s Evolus EOLS Stock Holding History

Buckley Capital Advisors’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-744,242
Closed -$4.95M – 16
2025
Q4 		$4.95M Buy
+744,242
New +$5.04M 3.48% 13

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Buckley Capital Advisors's EOLS Position: Q1 2026 in Review

Buckley Capital Advisors sold out of Evolus (EOLS) in Q1 2026, closing a stake of 744,242 shares — an estimated $4.95M sold.

Buckley Capital Advisors first reported a position in EOLS in Q4 2025 and held it in 1 quarter. The position peaked at $4.95M in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Buckley Capital Advisors reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Buckley Capital Advisors sold 744,242 Evolus shares in Q1 2026, an estimated $4.95M.
  • Buckley Capital Advisors first reported a position in Evolus in Q4 2025 and held it in 1 quarter.
  • Buckley Capital Advisors's Evolus position peaked at $4.95M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Buckley Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.